i.osei

TL2 Moderator · Osijek

Contributes reviews on supplier material. Based in Osijek.

Joined 10 February 2025 · last posted 6d

76 posts, newest first. Showing up to 150.

What to bring: records that a clinician can actually use — a second dataset Replied, post #63 · Clinical › Prescriber conversations · 22 Jul 2026 · 2 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #81 · Compounds › Retatrutide · 21 Jul 2026 · 12 likes This follows post #78 rather than contradicting it. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #95 · Compounds › Repair & healing peptides · 21 Jul 2026 · 7 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #88 · Practice › Interactions · 18 Jul 2026 · 1 like Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #67 · Practice › Dosing & titration · 15 Jul 2026 · 12 likes post #66 is right about the mechanism and I think understates the practical bit. Steady state means the plasma concentration is stable from dose to dose. That happens…
Revisiting: How this community labels and discusses unrefereed work Replied, post #24 · Evidence › Preprints · 14 Jul 2026 · 21 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #121 · Practice › Reconstitution · 12 Jul 2026 · 25 likes Picking up post #118: that is the part I would want checked first. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on…
What steady state means for the decision to escalate Replied, post #24 · Practice › Dosing & titration · 5 Jul 2026 · 0 likes On post #20 — agreed on the reasoning, with one qualification. Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #2 · Access › Insurance & coverage · 4 Jul 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down…
A fridge failure and how I assessed the contents afterwards Replied, post #16 · Devices › Cold chain · 3 Jul 2026 · 13 likes On post #12 — agreed on the reasoning, with one qualification. Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's labelling. Generally,…
Journal club: what we got wrong in an earlier session Replied, post #35 · Evidence › Journal club · 28 Jun 2026 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #42 · Clinical › Bloodwork · 9 Jun 2026 · 0 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
Talking to a therapist about this specifically Replied, post #11 · Wellbeing › Mental health · 9 Jun 2026 · 6 likes I read post #9 twice before replying, because I had assumed the opposite. Substance use: if someone has a history of substance use, appetite suppression and weight loss…
Tracking a shortage from primary sources rather than rumour Replied, post #38 · Access › Shortages · 6 Jun 2026 · 0 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
Asking a follow-up: new topic or new reply? Replied, post #2 · Start Here › How to Ask · 5 Jun 2026 · 1 like Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
A pooled estimate that changed when one trial was added Replied, post #4 · Evidence › Meta-analyses · 29 May 2026 · 4 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #81 · Compounds › Tirzepatide · 23 May 2026 · 17 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
Prescription requirements and telehealth models — a second dataset Replied, post #37 · Sourcing › Regulatory · 21 May 2026 · 15 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
The headache that turns out to be dehydration — the long version Replied, post #38 · Nutrition & Training › Hydration & electrolytes · 20 May 2026 · 1 like Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention for constipation alongside other measures.
Revisiting: Patterns that reliably precede a problem, documented Replied, post #6 · Sourcing › Red flags · 19 May 2026 · 25 likes Worth separating two things that post #2 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #22 · Analytics › COA interpretation · 2 May 2026 · 12 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
Shoulders, tangent skims, and defensible integration — the long version Replied, post #19 · Analytics › HPLC & UHPLC · 3 Apr 2026 · 5 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
Run-in periods and the population they select Replied, post #90 · Evidence › Trials · 29 Mar 2026 · 1 like Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #81 · Pharmacology › Pharmacokinetics · 24 Mar 2026 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Contributing data without breaching anyone's privacy Replied, post #64 · Data & Tools › Datasets · 6 Mar 2026 · 10 likes Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method) that someone reading it understands what it represents.
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #136 · Compounds › Semaglutide · 6 Mar 2026 · 11 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #86 · Access › International · 1 Feb 2026 · 8 likes On post #82 — agreed on the reasoning, with one qualification. Travel with medication: carrying a compound across borders is complicated by legal status. Documenting…
Second pass at: The topic list is dense — is that deliberate? Replied, post #55 · Meta › Site feedback · 27 Jan 2026 · 27 likes Feature requests: if the site would work better with a feature it does not have (better search, different filtering, new section) suggest it here with the reasoning.
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #17 · Clinical › Special populations · 21 Jan 2026 · 1 like This follows post #14 rather than contradicting it. Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #71 · Compounds › Oral incretins · 9 Dec 2025 · 4 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
Tracking a preprint to publication: a worked example Replied, post #36 · Evidence › Preprints · 3 Dec 2025 · 26 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
A payment that went through twice: how it was resolved Replied, post #9 · Sourcing › Payments · 21 Nov 2025 · 5 likes Documentation and tax implications: payments you make for compounds might have implications for tax reporting depending on your jurisdiction. Keeping clear records…
Tracking that stops updating and then resumes — the long version Replied, post #40 · Sourcing › Logistics · 19 Nov 2025 · 10 likes Worth separating two things that post #36 runs together. At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for…
Pen dose counters: what a click does and does not guarantee Replied, post #78 · Devices › Pens & autoinjectors · 17 Nov 2025 · 10 likes post #77 is right about the mechanism and I think understates the practical bit. Needle installation: some pens require a fresh needle for each injection; others have a…
Coverage in the US: a map of the usual obstacles Replied, post #10 · Regional › North America · 12 Nov 2025 · 0 likes Regional variation in North America: access differs substantially by US state and Canadian province. Postcode is a major determinant of access.
History of disordered eating and why it changes the conversation Replied, post #21 · Clinical › Special populations · 7 Nov 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
[2026 update] What steady state means for the decision to escalate Replied, post #13 · Practice › Dosing & titration · 5 Nov 2025 · 9 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
Where to report an adverse event officially, by region — a second dataset Replied, post #79 · Safety › Adverse events · 1 Nov 2025 · 0 likes Psychological adverse events: mood changes, anxiety, or suicidal ideation warrant discussion with a mental health professional. These are rare but real.
A parcel that arrived warm: a decision process, not a verdict Replied, post #105 · Practice › Storage & stability · 27 Oct 2025 · 1 like Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #124 · Compounds › Tirzepatide · 24 Oct 2025 · 2 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #7 · Outcomes › Body composition · 20 Oct 2025 · 0 likes On post #3 — agreed on the reasoning, with one qualification. Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and…
Second pass at: The mass-error checker and its intended scope Replied, post #40 · Data & Tools › Calculators · 16 Oct 2025 · 0 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
Revisiting: Power cut for eleven hours: how I assessed it afterwards Replied, post #4 · Practice › Storage & stability · 13 Oct 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Follow-up: Why appetite effects are mostly central Replied, post #62 · Pharmacology › Receptor biology · 9 Oct 2025 · 15 likes GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons (appetite and gastric motility), and on myocardium…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #111 · Evidence › Study critique · 16 Sep 2025 · 0 likes What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample…
Managing an unplanned gap in supply — what changed since Replied, post #60 · Access › Shortages · 12 Sep 2025 · 0 likes post #59 is right about the mechanism and I think understates the practical bit. Shortage predictions: regulators and suppliers issue shortage alerts before they become…
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #34 · Analytics › Method validation · 6 Sep 2025 · 0 likes This follows post #31 rather than contradicting it. Why two laboratories may disagree: after validating the same method, they may still report different purity on the…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #115 · Practice › Reconstitution · 29 Aug 2025 · 10 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Travel coolers and how long they really hold Replied, post #15 · Devices › Cold chain · 1 Aug 2025 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #51 · Evidence › Journal club · 23 Jun 2025 · 0 likes This follows post #48 rather than contradicting it. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #127 · Compounds › Cagrilintide & amylin analogues · 3 Jun 2025 · 1 like Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
A well-designed study with a badly written abstract Replied, post #67 · Evidence › Study critique · 7 May 2025 · 0 likes post #66 is right about the mechanism and I think understates the practical bit. Building consensus on which criticisms matter: if everyone agrees that the sample size…
Coverage for the indication versus for the drug Replied, post #53 · Access › Insurance & coverage · 4 May 2025 · 19 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
Reading an MS report that only gives you a single number Replied, post #69 · Analytics › Mass spectrometry · 3 May 2025 · 30 likes post #68 answers the question as asked. The question underneath it is different. Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect…
Coming back to: An 18-month record including the parts that went badly Replied, post #38 · Outcomes › Progress reports · 11 Apr 2025 · 4 likes This follows post #35 rather than contradicting it. Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid…
Cost per milligram, computed honestly across formats — the long version Replied, post #53 · Access › Pricing · 3 Apr 2025 · 0 likes Picking up post #50: that is the part I would want checked first. Compute cost per delivered dose at your dose if you want a number you can act on. That requires…
Requesting a page: what makes a good request Replied, post #33 · Documentation › Wiki requests · 24 Mar 2025 · 9 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
Counter-ion content and its effect on measured mass Replied, post #5 · Analytics › Mass spectrometry · 24 Mar 2025 · 2 likes This follows post #2 rather than contradicting it. Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to…
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #5 · Evidence › Journal club · 1 Mar 2025 · 3 likes This follows post #2 rather than contradicting it. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #32 · Evidence › Meta-analyses · 31 Jan 2025 · 32 likes Picking up post #29: that is the part I would want checked first. Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If…
UK access routes, dated and sourced — a second dataset Replied, post #31 · Regional › UK & Ireland · 26 Jan 2025 · 4 likes Worth separating two things that post #27 runs together. Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable.…
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #43 · Compounds › Oral incretins · 12 Jan 2025 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #16 · Pharmacology › Receptor biology · 1 Jan 2025 · 1 like I read post #14 twice before replying, because I had assumed the opposite. Bias and desensitisation: receptors can be biased (preferentially activating some downstream…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #92 · Compounds › Semaglutide · 24 Dec 2024 · 25 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #11 · Practice › Reconstitution · 14 Dec 2024 · 6 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #18 · Data & Tools › Calculators · 13 Dec 2024 · 0 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
Individual participant data versus aggregate data Replied, post #9 · Evidence › Meta-analyses · 28 Nov 2024 · 1 like Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
Washout with a one-week half-life: the arithmetic Replied, post #27 · Research Methods › N-of-1 designs · 27 Nov 2024 · 18 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #41 · Compounds › Tirzepatide · 17 Nov 2024 · 25 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
Blind submission and why it changes minds Replied, post #95 · Sourcing › Independent verification · 22 Oct 2024 · 4 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #3 · Compounds › Retatrutide · 24 Aug 2024 · 0 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
Why I ask for the gradient before I discuss the number Replied, post #15 · Analytics › HPLC & UHPLC · 23 Aug 2024 · 9 likes This follows post #12 rather than contradicting it. This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #30 · Clinical › Prescriber conversations · 1 Aug 2024 · 25 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #86 · Compounds › Retatrutide · 22 Jul 2024 · 0 likes post #85 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #11 · Practice › Dosing & titration · 6 Jul 2024 · 0 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
The mass-error checker and its intended scope Replied, post #93 · Data & Tools › Calculators · 3 Jul 2024 · 15 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…